Metastability as a candidate neuromechanistic biomarker of schizophrenia pathology. Hancock F, Rosas FE, McCutcheon RA, Cabral J, et al. PLoS One 2023;18:e0282707.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hancock F, Rosas FE, McCutcheon RA, Cabral J, et al. Metastability as a candidate neuromechanistic biomarker of schizophrenia pathology. PLoS One 2023;18:e0282707.
PMID: 36952467